Humedix Co. Ltd. | Mutual Funds
Mutual Funds that own Humedix Co. Ltd.
iShares Core MSCI Emerging Markets ETF
137,191
1.47%
0
0.01%
09/05/2018
Government Pension Fund - Global (The)
136,882
1.46%
88,253
0%
12/31/2017
Vanguard Total International Stock Index Fund
71,034
0.76%
0
0%
07/31/2018
DFA Emerging Markets Small Cap Series
47,028
0.5%
-2
0.02%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
37,251
0.4%
4,017
0%
04/30/2018
Vanguard Developed Markets Index Fund
30,141
0.32%
0
0%
07/31/2018
Vanguard FTSE All World (ex-US) Small Cap
13,470
0.14%
0
0.01%
07/31/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
11,788
0.13%
0
0%
09/05/2018
Mirae Asset TIGER Health Care ETF
10,830
0.12%
2,848
0.22%
04/30/2018
Vanguard Pacific Stock Index Fund
5,256
0.06%
0
0%
07/31/2018
| Address |
Unit 603, Anyang Mega Valley
Anyang GY 14056
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.humedix.com |
| Updated |
09/14/2018 |
| Humedix Co., Ltd. is a holding company, which engages in the manufacture and sale of hyaluronic acid based medical devices and arthritis treatment products. It offers dermal filler, specialty medicines, ophthalmic solvent, medicine raw materials, and cosmetics. The company was founded on February 27, 2003 and is headquartered in Anyang, South Korea. |
